CARA Therapeutics Company Profile

10:43 EST 15th December 2018 | BioPortfolio

Cara possesses both near-term clinical development opportunities, combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's first patented compound, CR665, has entered clinical testing for acute pain. This best-in-class compound possesses unique analgesic and anti-inflammatory activities appropriate for multiple therapeutic applications. In addition, Cara aims to develop a future pipeline of first-in-class molecules at novel analgesic and anti-inflammatory targets using its proprietary drug screening technology.


765 Old Saw Mill River Road
New York
United States of America


Phone: 914 347-4040
Fax: 914 347-4442

News Articles [753 Associated News Articles listed on BioPortfolio]

Cara Therapeutics Doses First Patient in Second Pivotal Phase 3 Efficacy Trial of Korsuva (CR845/difelikefalin) Injection in Hemodialysis Patients with Chronic Kidney Disease-Associated Pruritus

STAMFORD, Conn., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to allevi...

Cara Therapeutics starts dosing in KALM-2 trial

Cara Therapeutics has started dosing patients in the KALM-2 trial, a Phase lll pivotal study of KORSUVA (CR845/difelikefalin) injection to...Read More... The post Cara Therapeutics starts dosing in KA...

Cara Therapeutics reports $5m in license and milestone fee revenue in 3Q as it plows funds into clinical work

Derek Chalmers, Cara’s CEO, said he expected 2019 to be significant for Cara as it will bring readouts from its key Phase 3 trials of its drug Korsuva, which treats itchy skin related to renal failu...

Cara Therapeutics Inc. (CARA) CEO Derek Chalmers on Q3 2018 Results - Earnings Call Transcript

Cara Therapeutics (CARA) CR845 Phase 2/3 Trial Results For Postoperative Pain - Slideshow

Cara Therapeutics Appoints New CMO

Dr. Joana Goncalves brings more than 17 years of leadership experience in the biopharmaceutical industry to Cara

Former Celgene Exec Goncalves Joins Cara as Chief Medical Officer

Joana Goncalves has been named chief medical officer of Cara Therapeutics (NASDAQ: CARA). She comes to the Stamford, CT, company from Celgene (NASDAQ: CELG), where she was vice president, medical affa...

Cara Therapeutics' Stock Buoyed By Positive Korsuva Data For Post-Op Pain

Cara Therapeutics will discuss its options with regulators after positive top-line data from adaptive Phase II/III trial of its Korsuva...   

PubMed Articles [464 Associated PubMed Articles listed on BioPortfolio]

PS-CARA: Context-Aware Resource Allocation Scheme for Mobile Public Safety Networks.

The fifth-generation (5G) communications systems are expecting to support users with diverse quality-of-service (QoS) requirements. Beside these requirements, the task with utmost importance is to sup...

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

RNA-targeted therapeutics for lipid disorders.

To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.

A Review of Therapeutics in Clinical Development for Respiratory Syncytial Virus and Influenza in Children.

Respiratory syncytial virus (RSV) and influenza are important viral pathogens worldwide. Children, in particular, bear considerable burdens of morbidity and mortality associated with these viruses. Th...

La sarna noruega es una forma especial de escabiosis, infección cutánea producida por el Sarcoptes scabiei, infrecuente y muy contagiosa que afecta principalmente a pacientes inmunodeprimidos, ancia...

Clinical Trials [166 Associated Clinical Trials listed on BioPortfolio]

Metabolomic Approach to Evaluate the Effect of Orange Juice Intake in Healthy Humans (METABORANGE).

This study evaluates the effect of intake of two orange juice varieties in healthy adults. The participants will receive "Bahia" orange juice, "Cara-Cara" orange juice or a isocaloric cont...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Companies [1287 Associated Companies listed on BioPortfolio]

CARA Therapeutics

Cara possesses both near-term clinical development opportunities, combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's first patented compound, CR665, has enter...

The CARA Group, Inc.

CARA helps employees adapt to changes, learn new skills and abilities, and align on expectations. In short, CARA consulting solutions help people perform. We are thought partners,...


Cara Therapeutics, Inc.

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

More Information about "CARA Therapeutics" on BioPortfolio

We have published hundreds of CARA Therapeutics news stories on BioPortfolio along with dozens of CARA Therapeutics Clinical Trials and PubMed Articles about CARA Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CARA Therapeutics Companies in our database. You can also find out about relevant CARA Therapeutics Drugs and Medications on this site too.

Quick Search


Relevant Topics

An anesthesiologist (US English) or anaesthetist (British English) is a physician trained in anesthesia and perioperative medicine. Anesthesiologists are physicians who provide medical care to patients in a wide variety of (usually acute) situations. ...

Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Corporate Database Quicklinks

Searches Linking to this Company Record